Searched for
DOUBLE NEGATIVES
Weak monsoon may drag agri GDP into contractionIndian agriculture is at a crossroads, facing significant hurdles in the coming years. Analysts project little to no growth for agricultura...- Global rice production was 713 million tonnes per year during 2006-2015, saw growth: StudyGlobal rice production saw significant growth from the 1960s to the 2010s. This increase was primarily due to management decisions such as ...
- Sterlite Tech, HFCL shares rally up to 5% after 2-day fall. What’s triggering the surge?Shares of HFCL and Sterlite Technologies surged up to 5% on Friday, recovering from a two-day decline. This rebound follows a global tech s...
- India among Marriott's fastest-growing markets; footprint to double in 5 yearsMarriott International sees India as a key growth market. The company plans to double its hotel presence in India within five years. This e...
- Adani Energy Solutions’ IntelliSmart deal seen a costly but timely betIn a bold strategic move, Adani Energy Solutions has secured the smart metering firm IntelliSmart Infrastructure for a staggering ₹3,050 cr...
- Why market crashed today? Sensex plunges 719 points, Nifty closes below 23,150; 7 factors behind Rs 7 lakh crore sell-offIndian equity markets experienced a significant sell-off on Monday, with the Sensex and Nifty declining around 1% each. This downturn was d...
- 100 days of Iran war: India must brace for broad-based economic shockIn a volatile turn of events, escalating strikes between Iran and Israel are sending shockwaves that may reach India’s economy. As the spec...
- For investors with ability to understand and take risks: 6 small-caps from different sectors with upside potential of up to 26%The mood across global markets is not great at this point of time. News headlines point in directions we would rather they did not. But suc...
- Why is the US stock market down today? Dow Jones, S&P 500 and Nasdaq crash big as strong jobs report, rising Treasury yields and AI stock selloff shake Wall Street — here are today's biggest gainers and losersWhy is the stock market down today? A hotter-than-expected jobs report erased any lingering hope for near-term Federal Reserve rate cuts — ...
- India’s AI gap keeps global investors away, but valuations are turning attractive: Punita Kumar SinhaIndia is currently sidelined from the global AI investment boom due to its lack of semiconductor manufacturing. While the Indian IT sector ...
- Stocks in news: Tata Steel, ICICI Bank, Tata Motors, Vedanta, Maruti SuzukiIndian markets traded cautiously on Thursday's weekly expiry, with analysts observing a continued tussle for direction in the Nifty. Key co...
- India needs to remove tax friction for more FDIIndia is looking to boost foreign investment by reforming its tax system. Recent proposals aim to simplify taxes on foreign holdings. The c...
- Amit Khurana backs LTIMindtree, OFSS and eClerx as tactical betsAmit Khurana of Dolat Capital has upgraded India's IT sector, citing depressed valuations and rupee depreciation as key drivers. He believe...
- Vanguard slashes Ola value; War chokes PCB supplyAmerican investor Vanguard has sharply cut the fair value of Ola's parent company. This and more in today's ETtech Top 5.
- India plans to scrap capital gains tax on FPI investments in government securitiesIndia is set to eliminate capital gains tax for foreign portfolio investors on government securities to boost overseas capital inflows. Thi...
- Is SaaSpocalypse real? CLSA says maybe not and here’s whyInitial fears of an "SaaSpocalypse" following Anthropic's AI plug-in release have subsided. Brokerages now suggest AI is driving a shift to...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
Load More
